Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.

Oncotarget · 2017 · PMC5355317 · PMID 28060762

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Evaluating immunohistochemical staining of eEF2 and peEF2(T56) showed that this protein and its phosphorylation are highly significant prognostic markers for overall survival of HCC-patients.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.